Diazepam metabolism by rat and human liver in vitro: inhibition by mephenytoin.
1. Diazepam metabolism and its association with mephenytoin hydroxylase were studied in vitro using human and rat livers. 2. Enzyme kinetic parameters were obtained for the formation of p-hydroxydiazepam (p-hydroxy-DZP), N-desmethyldiazepam (NDZ), and temazepam (TMZ) from diazepam (DZP) in rat liver fractions. The Km values for formation in rat of p-hydroxy-DZP, NDZ and TMZ were 14 +/- 3 (SEM) microM, 44 +/- 4 and 63 +/- 8, respectively; clearance values calculated from Vmax/Km were 5.7, 3.2 and 4.9 ml/g per min, respectively. 3. Mephenytoin (MP) competitively inhibited, in rat liver, the formation of NDZ, but not the formation of p-hydroxy-DZP or TMZ; in human liver neither NDZ nor TMZ formation was inhibited by MP. 4. In seven different human livers the formation of p-hydroxy-DZP represented a minor pathway compared to the formation of NDZ and TMZ.
Beischlag
T V
TV
Department of Pharmacology, University of Toronto, Canada.
Kalow
W
W
Mahon
W A
WA
Inaba
T
T
D000818:Animals; D002849:Chromatography, Gas; D003975:Diazepam / Q000378:metabolism*; D006801:Humans; D006900:Hydroxylation; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008617:Mephenytoin / Q000494:pharmacology*; D008745:Methylation; D003708:Nordazepam / Q000378:metabolism / Q000493:pharmacokinetics; D011110:Polymorphism, Genetic / Q000502:physiology; D051381:Rats; D013693:Temazepam / Q000378:metabolism / Q000493:pharmacokinetics
D003708:Nordazepam; D013693:Temazepam; D003975:Diazepam; D008617:Mephenytoin